Jpmorgan Chase & Co »

Dyne Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.5M 54k 28.39
2023-12-31 $552k 42k 13.30
2023-09-30 $3.0M 338k 8.96
2023-06-30 $401k 36k 11.25
2023-03-31 $309k 27k 11.51
2022-12-31 $296k 20k 14.49
2022-06-30 $242k 35k 6.85
2022-03-31 $268k 28k 9.61
2021-12-31 $450k 38k 11.89
2021-03-31 $158k 10k 15.50
2020-12-31 $134k 6.4k 20.95